Institutional investors purchased a net $5.2 million shares of PCYC during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 75.92% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JANUS CAPITAL MANAGEMENT LLC Bought 2.4 Million shares of Pharmacyclics Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.6 Million shares of Pharmacyclics Inc
CAPITAL RESEARCH & MANAGEMENT CO... Bought 1.6 Million shares of Pharmacyclics Inc